-
-
-
-
-
-
-
H.C. Wainwright Reiterates Buy Rating on Karyopharm Therapeutics (KPTI)
-
-
-
-
-
-
-
Karyopharm Therapeutics Announces Closing of Public Offering of Common Stock and Exercise in Full of Underwriters’ Option to Purchase Additional Shares
-
-
-
-
-
-
-
Karyopharm Therapeutics (KPTI) PT Lowered to $29 at H.C. Wainwright
-
-
-
-
-
-
-
Karyopharm Therapeutics Announces Proposed Public Offering of Common Stock
-
-
-
-
-
-
-
H.C. Wainwright Starts Karyopharm Therapeutics (KPTI) at Buy
-
21,396 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

